ANTIINFECTIVES FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
OTHER BETA-LACTAM ANTIBACTERIALS
Last Updated on 02 Jul 2015 by EPG Health Media Staff
Suggest content to an epgonline.org editor - or let us know about a mistake you have spotted on this page
Rocephin is indicated for the treatment of the following infections in adults and children including term neonates (from birth):
Community acquired pneumonia
Hospital acquired pneumonia
Acute otitis media
Complicated urinary tract infections (including pyelonephritis)
Infections of bones and joints
Complicated skin and soft tissue infections
Rocephin may be used:
For treatment of acute exacerbations of chronic obstructive pulmonary disease in adults
For treatment of disseminated Lyme borreliosis (early (stage II) and late (stage III)) in adults and children including neonates from 15 days of age.
For Pre-operative prophylaxis of surgical site infections
In the management of neutropenic patients with fever that is suspected to be due to a bacterial infection
In the treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above
Rocephin should be co-administered with other antibacterial agents whenever the possible range of causative bacteria would not fall within its spectrum.
Consideration should be given to official guidelines on the appropriate use of antibacterial agents.
Rocephin vials Generic Name
POMSummary Product Characteristics (SPCs) Links
SPC - Rocephin 250mg, 1g and 2g vials (external site)